Literature DB >> 8457958

Clinical and epidemiologic characteristics of hepatitis C in a gastroenterology/hepatology practice in Ottawa.

L J Scully1, S Mitchell, P Gill.   

Abstract

OBJECTIVE: To examine the clinical and epidemiologic features of hepatitis C virus (HCV) infection in a gastroenterology/hepatology practice in Ottawa.
DESIGN: Retrospective chart review. PATIENTS: Sixty-three consecutive patients found to be anti-HCV positive. Their charts were analysed with respect to risk factors, history of hepatitis, serum aspartate aminotransferase (AST) levels and the presence of hepatitis B markers. The long-term sexual partners of 29 patients agreed to undergo HCV antibody testing.
RESULTS: Of the patients 48 (76%) had been exposed to HCV parenterally: 27 used intravenous drugs, and 21 had received blood or blood products. Eleven patients did not have any known risk factor (sporadic infection), but eight of them had lived in countries where hepatitis C may be more prevalent; the other three had locally acquired infection. The mean serum AST level at the first visit was 140 (normally less than 40) IU/L. At least one hepatitis B marker was identified in 33% of the patients. None of the sexual partners who were tested were anti-HCV positive.
CONCLUSION: Most cases of hepatitis C in Ottawa are acquired through parenteral exposure; sexual transmission is rare. Sporadic infection in the Ottawa region is rare but may be more common in people from countries with a higher prevalence rate of hepatitis C. Most cases of hepatitis C are asymptomatic.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8457958      PMCID: PMC1490869     

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


  20 in total

1.  Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome.

Authors:  Q L Choo; G Kuo; A J Weiner; L R Overby; D W Bradley; M Houghton
Journal:  Science       Date:  1989-04-21       Impact factor: 47.728

2.  Risk for non-A, non-B (type C) hepatitis through sexual or household contact with chronic carriers.

Authors:  J E Everhart; A M Di Bisceglie; L M Murray; H J Alter; J J Melpolder; G Kuo; J H Hoofnagle
Journal:  Ann Intern Med       Date:  1990-04-01       Impact factor: 25.391

3.  Recombinant immunoblot assay for hepatitis C virus antibody as predictor of infectivity.

Authors:  F Ebeling; R Naukkarinen; J Leikola
Journal:  Lancet       Date:  1990-04-21       Impact factor: 79.321

4.  Antibodies to hepatitis C virus in French blood donors.

Authors:  C Janot; A M Couroucé; M Maniez
Journal:  Lancet       Date:  1989-09-30       Impact factor: 79.321

5.  Antibodies to hepatitis C virus in Italian blood donors.

Authors:  G Sirchia; A Bellobuono; A Giovanetti; M Marconi
Journal:  Lancet       Date:  1989-09-30       Impact factor: 79.321

6.  Mother to infant transmission of hepatitis C virus infection.

Authors:  R Wejstål; S Hermodsson; S Iwarson; G Norkrans
Journal:  J Med Virol       Date:  1990-03       Impact factor: 2.327

7.  Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis.

Authors:  H J Alter; R H Purcell; J W Shih; J C Melpolder; M Houghton; Q L Choo; G Kuo
Journal:  N Engl J Med       Date:  1989-11-30       Impact factor: 91.245

8.  Hepatitis C virus antibodies among risk groups in Spain.

Authors:  J I Esteban; R Esteban; L Viladomiu; J C López-Talavera; A González; J M Hernández; M Roget; V Vargas; J Genescà; M Buti
Journal:  Lancet       Date:  1989-08-05       Impact factor: 79.321

9.  Anti-hepatitis C virus (HCV) screening at a Canadian Red Cross center: significance of a positive c100 HCV enzyme-linked immunosorbent assay.

Authors:  A Giulivi; M T Aye; E Gray; V Scalia; P Gill; G Cheng
Journal:  Transfusion       Date:  1992-05       Impact factor: 3.157

10.  Detection of hepatitis C viral sequences in non-A, non-B hepatitis.

Authors:  A J Weiner; G Kuo; D W Bradley; F Bonino; G Saracco; C Lee; J Rosenblatt; Q L Choo; M Houghton
Journal:  Lancet       Date:  1990-01-06       Impact factor: 79.321

View more
  3 in total

Review 1.  Current status of hepatitis C in Canada.

Authors:  S Zou; M Tepper; A Giulivi
Journal:  Can J Public Health       Date:  2000 Jul-Aug

2.  Characteristics of hepatitis C virus infection in HIV-infected people.

Authors:  C L Cooper; A D Badley; J B Angel
Journal:  Can J Infect Dis       Date:  2001-05

3.  Viral hepatitis and the surgeon.

Authors:  G Y Minuk; A J Cohen; N Assy; M Moser
Journal:  HPB (Oxford)       Date:  2005       Impact factor: 3.647

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.